Fungal infections can lead to severe illness or death, particularly in immunocompromised individuals. Antifungal prophylaxis aims to reduce the incidence of these infections, thereby decreasing morbidity and mortality rates. The [epidemiological](href) impact is significant as it also reduces the burden on healthcare systems by preventing costly and prolonged treatments for established infections.
